Mariner
EW icon

Mariner’s Edwards Lifesciences EW Stock Holding History

Mariner’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.9M Sell
186,466
-17,803
-9% -$1.47M 0.02% 574
2025
Q4 		$17.4M Sell
204,269
-31,959
-14% -$2.62M 0.02% 494
2025
Q3 		$18.4M Sell
236,228
-211,104
-47% -$16.5M 0.02% 445
2025
Q2 		$35M Sell
447,332
-7,136
-2% -$532K 0.05% 291
2025
Q1 		$32.9M Buy
454,468
+2,199
+0.5% +$157K 0.05% 282
2024
Q4 		$33.5M Sell
452,269
-19,782
-4% -$1.38M 0.06% 272
2024
Q3 		$31.2M Buy
472,051
+323,516
+218% +$23.5M 0.06% 281
2024
Q2 		$13.7M Sell
148,535
-16,608
-10% -$1.47M 0.03% 422
2024
Q1 		$15.8M Buy
165,143
+6,365
+4% +$535K 0.03% 381
2023
Q4 		$12.1M Buy
158,778
+3,655
+2% +$254K 0.03% 419
2023
Q3 		$10.7M Sell
155,123
-306
-0.2% -$24.6K 0.03% 411
2023
Q2 		$14.7M Sell
155,429
-6,722
-4% -$584K 0.04% 345
2023
Q1 		$13.4M Buy
162,151
+3,029
+2% +$238K 0.04% 357
2022
Q4 		$11.9M Sell
159,122
-43,184
-21% -$3.33M 0.04% 371
2022
Q3 		$16.7M Buy
202,306
+11,086
+6% +$1.07M 0.07% 251
2022
Q2 		$18.2M Sell
191,220
-14,281
-7% -$1.48M 0.07% 241
2022
Q1 		$24.2M Buy
205,501
+42,884
+26% +$4.81M 0.09% 220
2021
Q4 		$21.1M Sell
162,617
-24,246
-13% -$2.83M 0.09% 213
2021
Q3 		$21.2M Buy
186,863
+22,248
+14% +$2.54M 0.11% 190
2021
Q2 		$17M Buy
164,615
+3,839
+2% +$362K 0.11% 184
2021
Q1 		$13.4M Sell
160,776
-3,787
-2% -$320K 0.09% 191
2020
Q4 		$15M Buy
164,563
+2,594
+2% +$215K 0.12% 179
2020
Q3 		$12.9M Buy
161,969
+6,142
+4% +$479K 0.12% 174
2020
Q2 		$10.8M Buy
155,827
+2,290
+1% +$163K 0.11% 184
2020
Q1 		$9.66M Buy
153,537
+11,733
+8% +$846K 0.12% 170
2019
Q4 		$11M Buy
141,804
+20,394
+17% +$1.59M 0.11% 179
2019
Q3 		$8.9M Sell
121,410
-4,722
-4% -$332K 0.11% 184
2019
Q2 		$7.77M Buy
126,132
+9,120
+8% +$551K 0.09% 204
2019
Q1 		$7.46M Buy
117,012
+86,640
+285% +$4.94M 0.11% 194
2018
Q4 		$1.55M Sell
30,372
-8,046
-21% -$407K 0.03% 364
2018
Q3 		$2.23M Sell
38,418
-15
-0% -$734 0.06% 272
2018
Q2 		$1.86M Sell
38,433
-1,512
-4% -$70.6K 0.05% 286
2018
Q1 		$1.86M Sell
39,945
-4,875
-11% -$212K 0.07% 231
2017
Q4 		$1.68M Buy
44,820
+9,822
+28% +$360K 0.07% 228
2017
Q3 		$1.27M Buy
34,998
+16,494
+89% +$629K 0.06% 231
2017
Q2 		$729K Sell
18,504
-2,178
-11% -$79.5K 0.03% 288
2017
Q1 		$649K Buy
+20,682
New +$648K 0.03% 340
2016
Q4 		– Sell
-5,181
Closed -$208K – 625
2016
Q3 		$208K Buy
+5,181
New +$195K 0.01% 544

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Mariner's EW Position: Q1 2026 in Review

Mariner reduced its Edwards Lifesciences (EW) stake by 8.7% in Q1 2026, selling an estimated $1.47M and leaving 186,466 shares worth $14.9M. The position accounts for 0.02% of the portfolio, ranked #574.

Mariner first reported a position in EW in Q3 2016 and has held it in 38 quarters since. The position peaked at $35M in Q2 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Mariner held 186,466 shares of Edwards Lifesciences worth $14.9M as of Q1 2026.
  • Mariner sold 17,803 Edwards Lifesciences shares in Q1 2026, an estimated $1.47M.
  • Edwards Lifesciences made up 0.02% of Mariner's portfolio in Q1 2026, its #574 holding.
  • Mariner first reported a position in Edwards Lifesciences in Q3 2016 and has held it in 38 quarters since.
  • Mariner's Edwards Lifesciences position peaked at $35M in Q2 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.